Characterization of human tumor cell lines transduced with the cDNA encoding either tumor necrosis factor α (TNF-a) or interleukin-2 (IL-2)
- 5 May 1993
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 161 (1) , 77-90
- https://doi.org/10.1016/0022-1759(93)90199-h
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: Analysis by cytokine secretionCancer Immunology, Immunotherapy, 1993
- Characterization of Lymphocytes Infiltrating Human Breast Cancer, Specific Immune Reactivity Detected by Measuring Cytokine SecretionJournal of Immunotherapy, 1992
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo.The Journal of Experimental Medicine, 1991
- Interleukin 2‐dependent activation of tumor‐specific cytotoxic T lymphocytes in vivoEuropean Journal of Immunology, 1991
- Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.The Journal of Experimental Medicine, 1990
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990
- Murine interleukin-4 displays potent anti-tumor activity in vivoCell, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Tumors secreting human TNF/cachectin induce cachexia in miceCell, 1987